Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Spinning? I see none by greeneyes111

<by suggesting TPL is in breach of the Master Agreement, a conclusion which can in NO way be arrived at from their default on a subsequent, separate and unrelated business loan.>

Agreed. That would not be a conclusion. But it certainly does get one to thinking about the possibility. If TPL does not have the funds to repay PTSC, it may not have paid the people at Alliacense either. I would think that would potentially be a breach of the MA. In which case, the licensing would have come to a hault. And in which case the productive licensing needs to be restarted somehow. Per the 10Q.

<The Company is working aggressively to resolve this issue and to provide for the resumption of productive license activity from the MMP™ portfolio.>

Isn't licensing TPL's responsibility? They didn't say TPL is working to resolve......The company = PTSC. Why would PTSC be working to resolve and not TPL?

Opty

Share
New Message
Please login to post a reply